BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

myogen seattle Pages on BioPortfolio:

BioPortfolio - Myogen
Boulder County Business Review: Oct 30 2008 9:59PM Matching: myogen. Gilead Signs Lease to Grow in Seattle, Despite Aztreonam Delay ...
http://www.bioportfolio.com/biocorporate/7315-Myogen.html...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...

Results from other life science and pharmaceutical sites:

BioPortfolio - Myogen
Boulder County Business Review: Oct 30 2008 9:59PM Matching: myogen. Gilead Signs Lease to Grow in Seattle, Despite Aztreonam Delay ...
http://www.bioportfolio.com/biocorporate/7315-Myogen.html...

Expression of myogenic regulatory proteins (myogen...[Am J Pathol ...
Department of Pathology, University of Washington, Seattle 98195, USA. The distinction of rhabdomyosarcoma (RMS) from other small blue round cell tumors of
...
http://www.ncbi.nlm.nih.gov/pubmed/7495304...

A critical developmental role for tgfbr2 in myogen...[J Mol Cell ...
Department of Medicine, University of Washington Box 357710, 1959 NE Pacific Street, Seattle, WA 98195-7710, USA. Smooth muscle cell (SMC)-specific deletion
...
http://view.ncbi.nlm.nih.gov/pubmed/16887142...

Niche indications could drive higher valuations - Nature Biotechnology
6 Dec 2006 ... The Myogen acquisition helps cover a pipeline gap that Gilead faces that ... They point to Corus Pharma of Seattle, another of Gilead's ...
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1457....

BioWorld Today
8 Nov 2007 ... And last year, Gilead got a big boost to its pulmonary pipeline, with the acquisitions of Denver-based Myogen Inc. and Seattle-based Corus ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

Genentech faces the consequences of growth : Article : Nature ...
Late last year, the Foster City, California–based biotech purchased two companies—Seattle-based Corus Pharma and Myogen of Westminster, Colorado—in part
to ...
http://www.nature.com/nbt/journal/v25/n4/full/nbt0407-371.ht...

Fat-Reduced Diet May Not Reduce Risk for Cancer or CVD
... PhD, from the Fred Hutchinson Cancer Institute in Seattle, Washington, ... Searle, Pharmacia, Boehringer, Myogen, Merck Sharp & Dohme, and Mylan-Bertek.
...
http://www.medscape.com/viewarticle/523078...

Washout of heme-containing proteins dramatically i...[J Pharmacol ...
Inflammation Research, Amgen Inc., Seattle, WA 98119, USA. kelly.pitts@myogen. com. INTRODUCTION: Methods to determine infarct size following ...
http://www.ncbi.nlm.nih.gov/pubmed/16931060...

License
Seattle, is working to develop viable vaccines based. on Johnston’s work. ... Myogen has. licensed some of Olson’s discoveries and provides ...
http://www.utsouthwestern.edu/vgn/images/portal/cit_56417/8/...

Box 1 - Nature Biotechnology
Seattle Genetics (Seattle) appointed Douglas E. Williams as senior v.p. for R&D ... (d) Genitope (Redwood City, CA, USA) $33.3 million; (e) Myogen (Denver) ...
http://www.nature.com/nbt/journal/v22/n1/box/nbt0104-121_BX1...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.